Literature DB >> 3197828

A case of carnitine palmitoyltransferase II deficiency in human skeletal muscle.

R Singh1, I M Shepherd, J P Derrick, R R Ramsay, H S Sherratt, D M Turnbull.   

Abstract

A 20-year-old man was shown to have a deficiency of carnitine palmitoyltransferase (CPT) II in skeletal muscle. The evidence was: (i) there was no significant oxidation of [9,10-3H]-palmitate or of [1-14C]palmitate in mitochondrial fractions from fresh skeletal muscle from the patient; (ii) all the CPT activity in a homogenate of fresh muscle from the patient was overt (CPT I) with no increase in activity after the inner membrane was disrupted; (iii) all the CPT activity in the patient's muscle was inhibited by malonyl-CoA; and (iv) an immunoreactive peptide of 67 kDa corresponding to CPT II, present in mitochondria from controls, was absent in those from the patient.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3197828     DOI: 10.1016/0014-5793(88)81044-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  Carnitine palmitoyltransferase in human erythrocyte membrane. Properties and malonyl-CoA sensitivity.

Authors:  R R Ramsay; G Mancinelli; A Arduini
Journal:  Biochem J       Date:  1991-05-01       Impact factor: 3.857

Review 2.  Mammalian mitochondrial beta-oxidation.

Authors:  S Eaton; K Bartlett; M Pourfarzam
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

3.  Inhibition of carnitine palmitoyltransferase in normal human skeletal muscle and in muscle of patients with carnitine palmitoyltransferase deficiency by long- and short-chain acylcarnitine and acyl-coenzyme A.

Authors:  S Zierz; S Neumann-Schmidt; F Jerusalem
Journal:  Clin Investig       Date:  1993-10

4.  Biochemical evidence for heterozygosity in muscular carnitine palmitoyltransferase deficiency.

Authors:  S Zierz; R R Mundegar; F Jerusalem
Journal:  Clin Investig       Date:  1993-12

5.  Characterisation of carnitine palmitoyltransferases in patients with a carnitine palmitoyltransferase deficiency: implications for diagnosis and therapy.

Authors:  J Schaefer; S Jackson; F Taroni; P Swift; D M Turnbull
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-02       Impact factor: 10.154

6.  Molecular analysis of carnitine palmitoyltransferase II deficiency with hepatocardiomuscular expression.

Authors:  J P Bonnefont; F Taroni; P Cavadini; C Cepanec; M Brivet; J M Saudubray; J P Leroux; F Demaugre
Journal:  Am J Hum Genet       Date:  1996-05       Impact factor: 11.025

Review 7.  Muscle Carnitine Palmitoyltransferase II Deficiency: A Review of Enzymatic Controversy and Clinical Features.

Authors:  Diana Lehmann; Leila Motlagh; Dina Robaa; Stephan Zierz
Journal:  Int J Mol Sci       Date:  2017-01-03       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.